Alnylam Pharmaceuticals
ALNY
#660
Rank
โ‚ฌ33.90 B
Marketcap
253,94ย โ‚ฌ
Share price
0.62%
Change (1 day)
-5.83%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company